DHL opens new state-of-the-art Life Sciences facility at Dublin Airport
Global logistics provider DHL Supply Chain is today opening a new pharmaceutical grade facility in Ireland.
List view / Grid view
Global logistics provider DHL Supply Chain is today opening a new pharmaceutical grade facility in Ireland.
The FDA has approved the cryopreserved formulation of ReNeuron’s human retinal progenitor cell (hRPC) therapeutic candidate...
The EMA has approved Janssen's continuous manufacturing (CM) with real-time release testing for the production of Prezista (darunavir)...
A plan to tackle “serious flaws in the creation, dissemination and implementation of medical evidence” is set out by experts from The BMJ and Oxford University’s Centre for Evidence Based Medicine.
The new report highlights the significant difficulties patients and some healthcare professionals face in using evidence from research to judge the benefits and harms of medicines, and calls for concerted action to improve the information patients receive.
The Global Access to Healthcare Index measures how healthcare systems across 60 countries are working to solve the most pressing healthcare needs...
A new deal on the breast cancer drug trastuzumab emtansine means that it can now be recommended for routine funding.
The FDA has accepted Sandoz’s New Drug Application for fluticasone propionate / salmeterol combination product, a generic version of Advair Diskus...
More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research finds...
The Association for Accessible Medicines (AAM) applauded the US Supreme Court’s decision this week in Sandoz Inc. v. Amgen Inc. that will help speed patient access to biosimilar versions of expensive brand-name biologic medicines.
In 2018, industry leaders from pharma, biotech and clinical research organisations will advance the participation of patients in clinical trials...
SmartAction and EndPoint Technologies have formed a strategic partnership to expand the availability of AI-powered customer technology.
Valeant Pharmaceuticals has entered into an agreement to sell its iNova Pharmaceuticals business for $930 million in cash.
A new report released by the UK BioIndustry Association (BIA) shows that the UK maintained its strong leadership position in European biotech funding last year and has the strongest pipeline in Europe for future drug development.
Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss.